Raymond James Financial
ATRC icon

Raymond James Financial’s AtriCure ATRC Stock Holding History

Raymond James Financial’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.44M Buy
266,055
+49,148
+23% +$1.38M ﹤0.01% 2405
2026
Q1 		$6.13M Sell
216,907
-555
-0.3% -$18.9K ﹤0.01% 2437
2025
Q4 		$8.74M Sell
217,462
-19,816
-8% -$726K ﹤0.01% 2086
2025
Q3 		$8.36M Sell
237,278
-15,245
-6% -$525K ﹤0.01% 2067
2025
Q2 		$8.28M Buy
252,523
+5,087
+2% +$165K ﹤0.01% 2010
2025
Q1 		$7.98M Buy
247,436
+125,845
+103% +$4.67M ﹤0.01% 1989
2024
Q4 		$3.72M Buy
+121,591
New +$3.91M ﹤0.01% 2516

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Raymond James Financial's ATRC Position: Q2 2026 in Review

Raymond James Financial increased its AtriCure (ATRC) stake by 23% in Q2 2026, buying an estimated $1.38M and bringing the position to 266,055 shares worth $7.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Raymond James Financial first reported a position in ATRC in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.74M in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Raymond James Financial held 266,055 shares of AtriCure worth $7.44M as of Q2 2026.
  • Raymond James Financial bought 49,148 AtriCure shares in Q2 2026, an estimated $1.38M.
  • AtriCure made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2405 holding.
  • Raymond James Financial first reported a position in AtriCure in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's AtriCure position peaked at $8.74M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.